Below are the most recent publications written about "Antitubercular Agents" by people in Profiles.
-
Oluoch PO, Koh EI, Proulx MK, Reames CJ, Papavinasasundaram KG, Murphy KC, Zimmerman MD, Dartois V, Sassetti CM. Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection. Proc Natl Acad Sci U S A. 2025 Mar 04; 122(9):e2417525122.
-
Jaecklein E, Papavinasasundaram K, Ostroff GR, Sassetti C, Soto ER. Targeted delivery of antitubercular drugs using glucan lipid particles. Microbiol Spectr. 2025 Mar 04; 13(3):e0274424.
-
Nancy Pandiarajan A, Kumar NP, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S, Bethunaickan R, Viswanathan V, Kornfeld H, Babu S. Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes. Pathogens. 2025 Feb 04; 14(2).
-
Luna MJ, Oluoch PO, Miao J, Culviner P, Papavinasasundaram K, Jaecklein E, Shell SS, Ioerger TR, Fortune SM, Farhat MR, Sassetti CM. Frequently arising ESX-1-associated phase variants influence Mycobacterium tuberculosis fitness in the presence of host and antibiotic pressures. mBio. 2025 Mar 12; 16(3):e0376224.
-
Zhao X, Di J, Luo D, Verma R, Verma SK, Verma S, Ravindar L, Koshle A, Dewangan HK, Gupta R, Chandra S, Deshpande S, Vaishnav Y, Rakesh KP. Thiazole - A promising scaffold for antituberculosis agents and structure-activity relationships studies. Bioorg Chem. 2025 Jan; 154:108035.
-
Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh CR, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India. Clin Infect Dis. 2024 Oct 15; 79(4):1034-1038.
-
Pandiarajan AN, Kumar NP, Selvaraj N, Ahamed SF, Viswanathan V, Thiruvengadam K, Hissar S, Shanmugam S, Bethunaickan R, Nott S, Kornfeld H, Babu S. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2024; 15:1392256.
-
Viswanathan V, Devarajan A, Kumpatla S, Dhanasekaran M, Babu S, Kornfeld H. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India. Diabetes Metab Syndr. 2023 Jul; 17(7):102801.
-
Kim S, Thal R, Szkwarko D. Management of Latent Tuberculosis Infection. JAMA. 2023 02 07; 329(5):421-422.
-
Vaz C, Jose NK, Tom JJ, Goodman GR, Lee JS, Padappayil RP, Madathil M, O'Cleirigh C, Rodrigues R, Chai PR. Formative acceptance of ingestible biosensors to measure adherence to TB medications. BMC Infect Dis. 2022 Sep 28; 22(1):754.